How Clinical Trial Planning and Strategy can save you time and money

 

 

One of the issues in clinical trial development is that the companies collect a lot of trial data at all stages – some industry reports suggest 5 to 10 times more than required. Collection, cleaning and analyzing that much data results in slowing down the entire trial process.

Lack of proper Clinical Trial Planning and a target patient set leads to trial investigators reaching out to more number of patients and performing more tests. The problem here is two-fold. First, getting a larger number of patients takes longer time – from searching to performing tests. Second, after the excessive data is collected, it needs to be cleaned up to meet the target needs of the trial and then analyzed - both causing unnecessary and avoidable delay in the trial and more money.

This problem can be solved by the early involvement of medical clinical strategy experts in clinical plan, trial design and CRF development. Doing proper due-dilligence before the trial starts on deciding which variables to measure and which patient population to target can streamline the process and yield several benefits:

• Selecting a well-defined patient population can help in reducing the number of subjects to enroll and saving the money to recruit them and then performing tests.
• Optimizing the number of variables to measure and the amount of data to collect can help in reducing the time to collect, clean and analyze that data.
• Less number of tests and data measurement will help in keeping the trial period for patients smaller, which will further help in reducing the patient drop out rates.

Clinical Strategies and Trial Planning can save you time and money.
Do you agree? What is your experience?